| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-19 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-14 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-13 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |